Ellenbarrie Industrial Gases Fair Value
Ellenbarrie Industrial Gases (ELLEN) average fair value is ₹243.5 across 6 valuation models — P/E Based Valuation, P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, Benjamin Graham Number, Discounted Cash Flow (DCF), vs a current market price of ₹279.0 (-12.72%), fair value range ₹0.21–₹671.68. Also explore ELLEN share price data to track price trends across different timeframes.
Fair Value Analysis Export
ELLEN Fair Value vs Current Price — Valuation Summary
ELLEN average fair value, fair value range, price gap and valuation status across 6 models: P/E Based Valuation, P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, Benjamin Graham Number, Discounted Cash Flow (DCF). For live price and a broader fundamental view, visit Ellenbarrie Industrial Gases screener.
P/E Based Valuation
P/B Based Valuation
Price-to-Sales Valuation
Asset-Based Valuation
Benjamin Graham Number
Discounted Cash Flow (DCF)
ELLEN Fair Value Analysis — Data Sources & Coverage
Ellenbarrie Industrial Gases financial data sources, valuation methods applied and sector benchmarks used — 2026 financial year. See ELLEN P/B ratio history to compare market price against book value per share.
Available Data Sources: Financial statements, balance sheet data , sector comparisons.
Data Currency: Financial data is from the current year (2026).
ELLEN vs Chemicals Sector Peers — P/E, P/B & Market Cap
Ellenbarrie Industrial Gases P/E ratio, P/B ratio and market capitalisation vs Chemicals sector peers — relative valuation comparison.
| Company | Symbol | P/E Ratio | P/B Ratio | Market Cap (₹ Cr) |
|---|---|---|---|---|
| Polychem | POLYCHEM | 2.75 | 1.37 | ₹79 |
| Mehul Colours | MEHUL | 13.51 | 1.71 | ₹71 |
| PB Global | PBGLOBAL | -0.06 | 0.01 | ₹0 |
| Omkar Pharmachem | OMKARPH | 158.33 | 0.52 | ₹20 |
| Citurgia Biochemicals | CITURGIA | -2327.6 | -156.31 | ₹1,568 |
Important Disclaimer
This fair value analysis is for informational and educational purposes only. The calculations are based on publicly available financial data and various valuation methodologies.
This analysis does not constitute investment advice, recommendations, or suggestions to buy, sell, or hold any securities. Past performance and financial data do not guarantee future results.
Please conduct your own research and consult with qualified financial advisors before making any investment decisions. Market conditions, company fundamentals, and other factors can significantly impact actual stock performance.